Zylox-Tonbridge Medical Technology Co., Ltd. (FRA:818)
Germany
· Delayed Price · Currency is EUR 2.500
0.00 (0.00%)
At close: Dec 4, 2025
FRA:818 Revenue
Zylox-Tonbridge Medical Technology had revenue of 481.97M CNY in the half year ending June 30, 2025, with 109.43% growth. This brings the company's revenue in the last twelve months to 898.46M, up 35.39% year-over-year. In the year 2024, Zylox-Tonbridge Medical Technology had annual revenue of 782.48M with 48.27% growth.
Revenue (ttm)
898.46M CNY
Revenue Growth
+35.39%
P/S Ratio
8.07
Revenue / Employee
1.03M CNY
Employees
875
Market Cap
861.33M EUR
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |